Guangjie Chen

Prof. Dr. Guangjie Chen

Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Molecular Immunology
Verified
Journal Article
Closed access
CLChengzhen Li
Chengzhen Li
YXYebin Xi
Yebin Xi
SLShan Li
Shan Li
QZQing Zhao
Qing Zhao
WCWenjing Cheng
Wenjing Cheng
Guangjie ChenGuangjie Chen
Guangjie Chen

28 July 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
XGXin Guo
Xin Guo
Guangjie ChenGuangjie Chen
Guangjie Chen
Rheumatoid arthritis (RA) is a common autoimmune disease with characteristics of synovial inflammation, pannus formation, cartilage destruction, and bone erosion. Further, the inflammation is linked to increased oxygen consumption, resulting in hypoxia within the inflammatory area. Hypoxia-inducible factor (HIF) was reported to be associated with adaptation to the hypoxic microenvironment in the RA synovium. Here, we have briefly summarized the structure and expression of HIF. Moreover, the function of HIF in inflammation, angiogenesis, cartilage damage, and immune cells of RA has been discussed.

1 January 2015 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
YXYunzhi Xu
Yunzhi Xu
Guangjie ChenGuangjie Chen
Guangjie Chen
Mast cells are important in innate immune system. They have been appreciated as potent contributors to allergic reaction. However, increasing evidence implicates the important role of mast cells in autoimmune disease like rheumatoid arthritis and multiple sclerosis. Here we review the current stage of knowledge about mast cells in autoimmune diseases.

1 January 2014 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
WCWenjing Cheng
Wenjing Cheng
Guangjie ChenGuangjie Chen
Guangjie Chen
Multiple sclerosis is an autoimmune disease with classical traits of demyelination, axonal damage, and neurodegeneration. The migration of autoimmune T cells and macrophages from blood to central nervous system as well as the destruction of blood brain barrier are thought to be the major processes in the development of this disease. Chemokines, which are small peptide mediators, can attract pathogenic cells to the sites of inflammation. Each helper T cell subset expresses different chemokine receptors so as to exert their different functions in the pathogenesis of MS. Recently published results have shown that the levels of some chemokines and chemokine receptors are increased in blood and cerebrospinal fluid of MS patients. This review describes the advanced researches on the role of chemokines and chemokine receptors in the development of MS and discusses the potential therapy of this disease targeting the chemokine network.

1 September 2016 in Modern Rheumatology
Verified
Journal Article
Closed access
Shicheng GuoShicheng Guo
Shicheng Guo
QZQi Zhu
Qi Zhu
TJTing Jiang
Ting Jiang
RWRongsheng Wang
Rongsheng Wang
YSYi Shen
Yi Shen
DHDongyi He
Dongyi He
Introduction: Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints. Recent evidence indicated the epigenetic changes may contribute to the pathogenesis of RA. Method: To understand the extent and nature of dysregulated DNA methylation in RA CD4T cells, we performed a genome-wide DNA methylation study in CD4 + T cells in 12 RA patients compared to 12 matched normal healthy controls. Cytosine methylation status was quantified with Illumina methylation 450K microarray. Result: The DNA methylation profiling showed 383 hyper- and 785 hypo-methylated genes in the CD4 + T cells of the RA patients (p < 3.4 × 10−7). Gene ontology analysis indicated transcript alternative splicing and protein modification mediated by DNA methylation might play an important role in the pathogenesis of RA. In addition, the result showed that human leukocyte antigen (HLA) region including HLA-DRB6, HLA-DQA1 and HLA-E was frequently hypomethylated, but HLA-DQB1 hypermethylated in CpG island region and hypomethylated in CpG shelf region in RA patients. Outside the MHC region, HDAC4, NXN, TBCD and TMEM61 were the most hypermethylated genes, while ITIH3, TCN2, PRDM16, SLC1A5 and GALNT9 are the most hypomethylated genes. Conclusion: Genome-wide DNA methylation profile revealed significant DNA methylation change in CD4 + T cells from patients with RA.

6 January 2021 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
FCFeiyang Cai
Feiyang Cai
SJShuxin Jin
Shuxin Jin
Guangjie ChenGuangjie Chen
Guangjie Chen
CD4+ T cells play a vital role in the adaptive immune system and are involved in the pathogenesis of many diseases, including cancer, autoimmune diseases, and chronic inflammation. As an important mechanism for energy storage, a lot of researches have clarified that metabolism imbalance interacts with immune disorder, and one leads to the other. Lipid metabolism has close relationship with CD4+ T cells. In this review, we discuss fatty acid, cholesterol, prostaglandin, and phospholipid metabolism in CD4+ T cell subsets. Fatty acid β‐oxidation (FAO) is activated in Th17 cell to support the proinflammatory function. Cholesterol promotes Th1, Th2, and Treg cell differentiation. In addition to glucose metabolism, lipid metabolism is also very important for immunity. Here, it is highlighted that lipid metabolism regulates CD4+ T cell differentiation and function and is related to diseases.